The prescription pain patch that helps him stay at the top of his game
Professional golfer James Hahn has partnered with IBSA Pharma Inc. to promote Licart®, the pharmaceutical company’s newest topical pain product. Licart (diclofenac epolamine) topical system 1.3% is the first and only once-a-day topical nonsteroidal anti-inflammatory drug (NSAID) approved by the Food and Drug Administration (FDA) to treat acute pain due to minor strains, sprains, and contusions.1
As part of the partnership, Hahn will wear the Licart logo on his clothing and will appear on social media and at in-person events to promote the brand. Hahn is both a spokesperson and a Licart patient.
As a successful golfer with a rigorous PGA Tour schedule, James is the perfect example of the type of active person who benefits from using Licart to treat acute localized back and muscle pain,” said Aldo Donati, chief executive officer, IBSA Pharma Inc. “Licart represents the next generation of NSAID patch technology from IBSA, the company that pioneered NSAID patch therapy with Flector (diclofenac epolamine) topical system 1.3%. Licart is absorbed through the skin and goes directly to the area where it is applied so other areas of your body do not get as much medication. Licart helps patients stay at the top of their game.”
Licart contains diclofenac epolamine, a widely used NSAID, which is delivered via a patented next-generation patch technology that allows for fast and sustained pain relief. Licart has been proven to provide significant pain relief within 1-3 hours after application and continue to relieve pain for 24 hours.²
Each carton of Licart contains 15 individually enveloped topical systems to last for 15 days. Patients simply peel Licart from its package and apply it where it hurts. Licart sticks to skin, is mess free, odorless, and won’t stain clothes.
“It’s amazing how easy it is to apply Licart and how helpful it has been for targeting my sore and painful areas to provide fast and long-lasting relief. It helps me focus on my game and not my pain. I’m so thrilled to be a part of the IBSA family and to welcome them into the world of elite golf,” said Hahn.
Hahn turned professional in 2003 and joined the PGA Tour in 2013. He has two wins on the PGA Tour. He also has professional victories on the Web.com Tour and Canadian Tour.
Licart is a prescription-only product available at most major retail pharmacies and through the Licart Direct Program, a network of participating mail-order pharmacies. These pharmacies can assist patients to access Licart at the lowest cost regardless of their insurance status. For more information about Licart and the Licart Direct Program, visit www.licart.com/patientsavings or speak with your physician.
About IBSA Pharma Inc.
IBSA Pharma Inc. is part of IBSA Group, which is headquartered in Lugano, Switzerland. The company is a world leader in the treatment of thyroid and musculoskeletal diseases and has a diversified product portfolio of prescription drugs. With products on five continents and over 90 countries, IBSA has a commitment to scientific research and improving the health of patients.
